VVOS icon

Vivos Therapeutics

19 hedge funds and large institutions have $434K invested in Vivos Therapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SWIG
1
Strategic Wealth Investment Group
Kentucky
$304K 128,789 +128,789 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$45.9K 20,691 +20,691 New
Commonwealth Equity Services
3
Commonwealth Equity Services
Massachusetts
$36K 16,000 +1,000 +7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$23.5K 10,579
TWP
5
Triad Wealth Partners
Kansas
$6.26K 2,818 +2,818 New
Credit Agricole
6
Credit Agricole
France
$5.25K 2,365
TRCT
7
Tower Research Capital (TRC)
New York
$5.07K 2,283 +554 +32%
NFSG
8
Newbridge Financial Services Group
Florida
$2.83K 1,275 -675 -35%
Osaic Holdings
9
Osaic Holdings
Arizona
$1.99K 898 +898 New
S
10
SignatureFD
Georgia
$1.21K 547
BTI
11
Blue Trust Inc
Georgia
$773 160
Group One Trading
12
Group One Trading
Illinois
$506 228
Bank of America
13
Bank of America
North Carolina
$229 103 +23 +29%
Morgan Stanley
14
Morgan Stanley
New York
$151 68 +1 +1%
KA
15
Kozak & Associates
Colorado
$118 49
GRP
16
Global Retirement Partners
California
$51 23
TWC
17
TD Waterhouse Canada
Ontario, Canada
$28 12 +12 New
SPIA
18
Steward Partners Investment Advisory
New York
$18 8
AC
19
Armistice Capital
New York
-103,582 Closed
Wells Fargo
20
Wells Fargo
California
-7 Closed
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$0 7
CFGS
22
Concourse Financial Group Securities
Alabama
FFA
23
Farther Finance Advisors
California